Abstract
Systemic primary carnitine deficiency is an autosomal recessive disorder caused by the deficiency of carnitine transporter. Main features are cardiomyopathy, myopathy and hypoglycemic encephalopathy. We report a Turkish case with a novel SLC22A5 gene mutation presented with a pure cardiac phenotype. During the 14-year follow-up study, cardiac functions were remained within a normal range with oral L-carnitine supplementation.
MeSH terms
-
Adolescent
-
Cardiomyopathies / drug therapy
-
Cardiomyopathies / genetics*
-
Carnitine / deficiency*
-
Carnitine / genetics
-
Carnitine / therapeutic use*
-
Child
-
Child, Preschool
-
Hormone Replacement Therapy
-
Humans
-
Hyperammonemia / drug therapy
-
Hyperammonemia / genetics*
-
Male
-
Muscular Diseases / drug therapy
-
Muscular Diseases / genetics*
-
Mutation*
-
Organic Cation Transport Proteins / genetics*
-
Solute Carrier Family 22 Member 5
-
Turkey
Substances
-
Organic Cation Transport Proteins
-
SLC22A5 protein, human
-
Solute Carrier Family 22 Member 5
-
Carnitine
Supplementary concepts
-
Systemic carnitine deficiency